TMPRSS2 and prostate cancer: Similar in vitro antiviral effects on SARS-CoV and MERS-CoV have also been described with protease inhibitors targeting the transmembrane serine protease 2 (TMPRSS2), an androgen-regulated gene commonly known in prostate cancer biology [42].